Effects of fluconazole on the metabolomic profile of Candida albicans

19Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

Background: Little is known about the effects of fluconazole on the metabolism of Candida albicans. We performed LC/MS-based metabolomic profiling of the response of C. albicans cells to increasing doses of fluconazole. Methods: C. albicans cells were cultured to mid-logarithmic growth phase in liquid medium and then inoculated in replicate on to nitrocellulose filters under vacuum filtration. Organisms were cultured to mid-logarithmic growth phase and treated with 0-4 mg/L fluconazole. Following metabolic quenching at mid-logarithmic growth phase, intracellular metabolites were extracted and analysed by LC/MS. Changes in pool sizes of individual metabolites were verified by Student's t-test, adjusted for multiple hypothesis testing by Benjamini-Hochberg correction. Distribution of metabolites was analysed by the Kyoto Encyclopedia of Genes and Genomes metabolic pathways database. Results: We reproducibly detected 64 metabolites whose identities were confirmed by comparison against a pure standard and a library of accurate mass-retention time pairs. These 64 metabolites were broadly representative of eukaryotic central metabolic pathways. Among them 12 had their mean abundance significantly altered in response to increasing fluconazole concentrations. Pool sizes of four intermediates of central carbon metabolism (α-ketoglutarate, glucose-6-phosphate, phenylpyruvate and ribose-5-phosphate) and mevalonate were increased by 0.5-1.5-fold (P ≤ 0.05). Five amino acids (glycine, proline, tryptophan, aminoisobutanoate and asparagine) and guanine were decreased by 0.5-0.75-fold (P ≤ 0.05). Conclusions: Fluconazole treatment of C. albicans resulted in increased central carbon and decreased amino acid synthesis intermediates, suggesting a rerouting of metabolic pathways. The function of these metabolomic changes remains to be elucidated; however, they may represent previously unrecognized mechanisms of metabolic injury induced by fluconazole against C. albicans.

References Powered by Scopus

More powerful procedures for multiple significance testing

2257Citations
N/AReaders
Get full text

Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance

1438Citations
N/AReaders
Get full text

Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations

1076Citations
N/AReaders
Get full text

Cited by Powered by Scopus

A novel mechanism of fluconazole: Fungicidal activity through dose-dependent apoptotic responses in Candida albicans

43Citations
N/AReaders
Get full text

Novel approaches for efficient antifungal drug action

28Citations
N/AReaders
Get full text

Fluconazole increases osmotic water transport in renal collecting duct through effects on aquaporin-2 trafficking

22Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Katragkou, A., Alexander, E. L., Eoh, H., Raheem, S. K., Roilides, E., & Walsh, T. J. (2016). Effects of fluconazole on the metabolomic profile of Candida albicans. Journal of Antimicrobial Chemotherapy, 71(3), 635–640. https://doi.org/10.1093/jac/dkv381

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

50%

Researcher 7

29%

Professor / Associate Prof. 3

13%

Lecturer / Post doc 2

8%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 9

36%

Immunology and Microbiology 6

24%

Chemistry 5

20%

Medicine and Dentistry 5

20%

Save time finding and organizing research with Mendeley

Sign up for free